About Enumeral Biomedica (OTCMKTS:ENUM)
Enumeral Biomedical Holdings, Inc., a biopharmaceutical company, engages in discovering and developing antibody immunotherapies that help the immune system fight cancer and other diseases. It is developing two antagonist PD-1 antibodies, such as ENUM 388D4 and ENUM 244C8 for use in treating cancer. The company is also developing antibody drug candidates for various immunomodulatory protein targets, including TIM-3, CD39, and TIGIT. Enumeral Biomedical Holdings, Inc. has collaboration agreements with Merck Sharp & Dohme Corp.; and The University of Texas MD Anderson Cancer Center, as well as a research contract with the National Cancer Institute. Enumeral Biomedical Holdings, Inc. was founded in 2009 and is based in Cambridge, Massachusetts.
Industry, Sector and Symbol
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Annual Sales$2.45 million
Price / Sales0.14
Price / CashN/A
Book Value$0.03 per share
Price / Book0.09
Return on Equity-1,157.75%
Return on Assets-497.92%
Enumeral Biomedica (OTCMKTS:ENUM) Frequently Asked Questions
What is Enumeral Biomedica's stock symbol?
Enumeral Biomedica trades on the OTCMKTS under the ticker symbol "ENUM."
How were Enumeral Biomedica's earnings last quarter?
Enumeral Biomedica (OTCMKTS:ENUM) issued its quarterly earnings results on Monday, August, 14th. The company reported ($0.02) EPS for the quarter. The firm had revenue of $0.19 million for the quarter. Enumeral Biomedica had a negative net margin of 1,945.52% and a negative return on equity of 1,157.75%. View Enumeral Biomedica's Earnings History.
Who are some of Enumeral Biomedica's key competitors?
Some companies that are related to Enumeral Biomedica include Atlas Resource Partners (ARPJQ), Education Management (EDMC), Quiksilver (ZQKSQ), Goodrich Petroleum (GDPMQ), DynaVox (DVOXQ), RAMBLER METALS & M (RBMTF), Terravia (TVIAQ), Thunderbird Resources Equity (GMXRQ), AFREN (AFRNF), Glori Energy (GLRI), BG Medicine (BGMD), Seal123 (WTSLQ), Deer Consumer Products (DEER), QF Liquidation (QTWWQ), China Gerui Advanced Materials Group (CHOPF), M Pharmaceutical (MPHMF), Azure Midstream Pa Com Unit Ltd Partner Int (AZURQ) and Roust (CEDCQ).
How do I buy Enumeral Biomedica stock?
Shares of Enumeral Biomedica can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Enumeral Biomedica's stock price today?
One share of Enumeral Biomedica stock can currently be purchased for approximately $0.00.
How big of a company is Enumeral Biomedica?
Enumeral Biomedica has a market capitalization of $390,000.00 and generates $2.45 million in revenue each year. The company earns $-11,850,000.00 in net income (profit) each year or ($0.17) on an earnings per share basis. Enumeral Biomedica employs 10 workers across the globe.
How can I contact Enumeral Biomedica?
Enumeral Biomedica's mailing address is 200 CambridgePark Drive Suite 2000, Cambridge MA, 02140. The company can be reached via phone at 617-945-9146 or via email at [email protected]
MarketBeat Community Rating for Enumeral Biomedica (ENUM)MarketBeat's community ratings are surveys of what our community members think about Enumeral Biomedica and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Enumeral Biomedica (OTCMKTS:ENUM) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
Enumeral Biomedica (OTCMKTS:ENUM) Earnings History and Estimates Chart
Enumeral Biomedica (OTCMKTS ENUM) Earnings History by Quarter
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|8/14/2017||Q2 2017||($0.02)||$0.19 million||View||N/A|
|5/22/2017||Q1 2017||($0.02)||$0.02 million||View||N/A|
|8/12/2015||Q2 2015||($0.04)||($0.04)||$0.10 million||$0.38 million||View||N/A|
|3/19/2015||Q4 2014||($0.05)||$0.06||$0.09 million||$0.04 million||View||N/A|
Enumeral Biomedica (OTCMKTS:ENUM) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Enumeral Biomedica (OTCMKTS:ENUM)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Enumeral Biomedica (OTCMKTS ENUM)
No insider trades for this company have been tracked by MarketBeat.com
Enumeral Biomedica (OTCMKTS ENUM) News Headlines
No headlines for this company have been tracked by MarketBeat.com
Enumeral Biomedica (OTCMKTS:ENUM) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
Enumeral Biomedica (OTCMKTS ENUM) Stock Chart for Thursday, December, 14, 2017